The biopharma drug development pathway: origins and comparison with small molecule discovery

Time: 3:00 – 4:00 pm (BST)

The biopharma drug development pathway: origins and comparison with small molecule discovery

In this webinar, Professor Alexander Breeze will provide a historical context for the development of modern biopharmaceutical drug discovery pathways. He will compare and contrast the evolution of biologics (large molecule) development with that of ‘traditional’ small molecule pharma R&D, from which the biopharmaceuticals processes have largely been modelled and adapted.

In this presentation, we will explore the scientific and clinical challenges, attrition/risk profiles, economic drivers, and licensing approaches across the key stages in discovery and development for the two contrasting modalities of therapeutic agent.

Along the way, Professor Breeze will touch on the factors behind the rapid rise in prominence of biopharmaceuticals, as well as the reasons that, despite this apparent conquest by biologics, small molecule therapeutics will remain an important tool in the clinician’s armoury.

Date

Sep 24 2020

Time

3:00 pm - 4:00 pm

Location

Online
Biochemical Society

Organiser

Biochemical Society
More info and register >
QR Code